Novartis (NVS) has agreed to acquire Regulus Therapeutics (RGLS) for an initial payment of $7.00 per share in cash at closing, or $800 million, Regulus said Wednesday.
Shares of Regulus more than doubled as intraday trading volume soared to over 23.4 million from a daily average of about 1.3 million.
Oddity Tech (ODD) reported Q1 adjusted earnings and sales late Tuesday above forecasts and raised its full-year EPS and revenue guidance.
Shares soared 26% as intraday trading volume surged to more than 4.2 million from a daily average of about 458,000.
Jeffs' Brands (JFBR) said Wednesday that it signed a definitive agreement to sell its Smart Repair Pro unit and its 49.1% stake in SciSparc Nutraceuticals to Plantify Foods.
Shares jumped 52% as intraday trading volume catapulted to over 85.8 million compared with a daily average of about 317,000.
Price: 113.49, Change: +0.04, Percent Change: +0.04
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。